Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statement of Changes in Stockholders' Equity (Unaudited)

v3.19.2
Condensed Consolidated Statement of Changes in Stockholders' Equity (Unaudited) - USD ($)
$ in Thousands
Total
Common Stock
Additional Paid-in Capital
Retained Earnings
Accumulated Other Comprehensive Income
Total New Residential Stockholders’ Equity
Noncontrolling Interests in Equity of Consolidated Subsidiaries
Equity, beginning balance (in shares) at Dec. 31, 2017   307,361,309          
Equity, beginning balance at Dec. 31, 2017 $ 4,796,162 $ 3,074 $ 3,763,188 $ 559,476 $ 364,467 $ 4,690,205 $ 105,957
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Dividends declared (337,999)     (337,999)   (337,999)  
Capital contributions 0            
Capital distributions (37,015)           (37,015)
Issuance of common stock (in shares)   28,750,000          
Issuance of common stock 482,253 $ 288 481,965     482,253  
Options exercise (in shares)   3,694,228          
Option exercise   $ 36 (36)        
Director share grants (in shares)   57,232          
Director share grants 1,019 $ 1 1,018     1,019  
Comprehensive income (loss)              
Net income (loss) 800,200     779,011   779,011 21,189
Net unrealized gain (loss) on securities 37,045       37,045 37,045  
Reclassification of net realized (gain) loss on securities into earnings 57,259       57,259 57,259  
Total comprehensive income (loss) 894,504         873,315 21,189
Equity, ending balance (in shares) at Jun. 30, 2018   339,862,769          
Equity, ending balance at Jun. 30, 2018 5,798,924 $ 3,399 4,246,135 1,000,488 458,771 5,708,793 90,131
Comprehensive income (loss)              
Goodwill 24,645            
Equity, beginning balance (in shares) at Dec. 31, 2018   369,104,429          
Equity, beginning balance at Dec. 31, 2018 6,088,295 $ 3,692 4,746,242 830,713 417,023 5,997,670 90,625
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Dividends declared (415,475)     (415,475)   (415,475)  
Capital contributions 0            
Capital distributions (25,001)           (25,001)
Issuance of common stock (in shares)   46,000,000          
Issuance of common stock $ 751,393 $ 460 750,933     751,393  
Options exercise (in shares) 2,041,222 348,613          
Option exercise $ 0 $ 3 (3)        
Purchase of noncontrolling interests in the Buyer 0            
Other dilution 0            
Director share grants (in shares)   67,738          
Director share grants 1,055 $ 1 1,054     1,055  
Comprehensive income (loss)              
Net income (loss) 130,892     113,651   113,651 17,241
Net unrealized gain (loss) on securities 359,515       359,515 359,515  
Reclassification of net realized (gain) loss on securities into earnings (89,844)       (89,844) (89,844)  
Total comprehensive income (loss) 400,563         383,322 17,241
Equity, ending balance (in shares) at Jun. 30, 2019   415,520,780          
Equity, ending balance at Jun. 30, 2019 6,800,830 $ 4,156 $ 5,498,226 $ 528,889 $ 686,694 $ 6,717,965 $ 82,865
Comprehensive income (loss)              
Goodwill $ 24,645